ResMed Inc. (RMD)
Largest Insider Buys in Sector
RMD Stock Price History Chart
RMD Stock Performance
About ResMed Inc.
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software …
Insider Activity of ResMed Inc.
Over the last 12 months, insiders at ResMed Inc. have bought $0 and sold $42.74M worth of ResMed Inc. stock.
On average, over the past 5 years, insiders at ResMed Inc. have bought $0 and sold $35.64M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 10,000 shares for transaction amount of $424,500 was made by SULPIZIO RICHARD (director) on 2006‑08‑21.
List of Insider Buy and Sell Transactions, ResMed Inc.
| 2024-11-01 | Sale | Global General Counsel | 69 <0.0001% | $242.00 | $16,698 | -0.27% | ||
| 2024-10-11 | Sale | Chief Commercial Officer, SaaS | 4,260 0.0029% | $238.48 | $1.02M | +0.08% | ||
| 2024-10-08 | Sale | Chief Financial Officer | 1,000 0.0007% | $233.47 | $233,470 | +1.79% | ||
| 2024-10-07 | Sale | Chief Executive Officer | 14,683 0.0096% | $231.91 | $3.41M | +3.34% | ||
| 2024-10-02 | Sale | director | 2,000 0.0013% | $237.20 | $474,400 | +0.39% | ||
| 2024-09-12 | Sale | Chief Commercial Officer, SaaS | 5,000 0.0034% | $252.56 | $1.26M | -4.25% | ||
| 2024-09-09 | Sale | Chief Executive Officer | 14,683 0.0099% | $248.38 | $3.65M | -3.63% | ||
| 2024-09-09 | Sale | Chief Financial Officer | 1,000 0.0007% | $246.42 | $246,420 | -3.63% | ||
| 2024-09-04 | Sale | director | 2,000 0.0013% | $239.90 | $479,800 | -1.29% | ||
| 2024-08-20 | Sale | Global General Counsel | 882 0.0006% | $231.00 | $203,742 | +8.61% | ||
| 2024-08-12 | Sale | President, SaaS Business | 10,000 0.0069% | $216.60 | $2.17M | +12.77% | ||
| 2024-08-08 | Sale | Chief Financial Officer | 1,000 0.0007% | $212.16 | $212,160 | +12.33% | ||
| 2024-08-07 | Sale | Chief Executive Officer | 14,683 0.0102% | $214.25 | $3.15M | +14.02% | ||
| 2024-08-05 | Sale | President, Asia Latin America | 48,000 0.0329% | $217.07 | $10.42M | +11.30% | ||
| 2024-07-08 | Sale | Chief Executive Officer | 14,683 0.0103% | $192.97 | $2.83M | 0.00% | ||
| 2024-07-08 | Sale | Chief Financial Officer | 1,000 0.0007% | $194.35 | $194,350 | 0.00% | ||
| 2024-06-10 | Sale | Chief Financial Officer | 1,000 0.0007% | $209.81 | $209,810 | +11.99% | ||
| 2024-06-07 | Sale | Chief Executive Officer | 14,683 0.01% | $211.66 | $3.11M | +12.16% | ||
| 2024-05-15 | Sale | director | 360 0.0002% | $218.29 | $78,584 | +1.31% | ||
| 2024-05-08 | Sale | Chief Financial Officer | 13,000 0.0088% | $211.37 | $2.75M | +3.64% |
Insider Historical Profitability
| SULPIZIO RICHARD | director | 26527 0.0181% | $245.67 | 1 | 1 | +6.07% |
Institutional Investor Ownership
| The Vanguard Group | $3.52B | 12.1 | 17.77M | +0.15% | +$5.21M | 0.07 | |
| BlackRock | $2.41B | 8.3 | 12.19M | -0.44% | -$10.62M | 0.05 | |
| State Street | $1.25B | 4.29 | 6.3M | +0.14% | +$1.77M | 0.05 | |
| BNY Mellon | $755.11M | 2.6 | 3.81M | +230.31% | +$526.5M | 0.14 | |
| Geode Capital Management | $676.12M | 2.33 | 3.42M | -0.35% | -$2.39M | 0.06 |